These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2673809)

  • 41. Monoclonal autoantibodies from insulin-dependent diabetic patients: autoantibodies against beta-cell surface or cytoplasmic antigens.
    Houssaint E; Pogu S; Ouary M; Sai P
    Clin Exp Immunol; 1990 Oct; 82(1):44-51. PubMed ID: 1698582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reevaluation of autoantibodies to islet cell membrane in IDDM. Failure to detect islet cell surface antibodies using human islet cells as substrate.
    Vives M; Somoza N; Soldevila G; Gomis R; Lucas A; Sanmarti A; Pujol-Borrell R
    Diabetes; 1992 Dec; 41(12):1624-31. PubMed ID: 1446804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Islet cell surface antibodies by an ELISA method in diabetic and nondiabetic patients.
    Betterle C; Presotto F; Magrin L; Caretto A; Pedini B; Zanchetta R
    J Endocrinol Invest; 1991 Apr; 14(4):293-7. PubMed ID: 1865079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ten-year follow-up study of islet-cell antibodies and childhood diabetes mellitus.
    Bruining GJ; Molenaar JL; Grobbee DE; Hofman A; Scheffer GJ; Bruining HA; de Bruyn AM; Valkenburg HA
    Lancet; 1989 May; 1(8647):1100-3. PubMed ID: 2566050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Islet-cell antibodies in IDDM and NIDDM in a Japanese population.
    Kobayashi T; Sawano S; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():271-4. PubMed ID: 6393435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Islet cell autoantibodies: pathobiology and clinical applications.
    Vardi P; Dibella EE; Pasquarello TJ; Srikanta S
    Diabetes Care; 1987; 10(5):645-56. PubMed ID: 3315517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation and partial characterization of monoclonal antibodies reactive with islet cell antigens.
    Witt S; Ziegler B; Waterstradt B; Besch W; Hehmke B; Ziegler M
    Exp Clin Endocrinol; 1987 Aug; 89(3):276-82. PubMed ID: 3311774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Islet cell antibody (ICA), islet cell surface antibody (ICSA)].
    Ishida T
    Nihon Rinsho; 1999 Dec; 57 Suppl():368-71. PubMed ID: 10778141
    [No Abstract]   [Full Text] [Related]  

  • 49. Characterization of monoclonal islet cell reactive autoantibodies from the diabetic biobreeding (BB/OK) rat.
    Ziegler B; Witt S; Kohnert KD; Schlosser M; Augstein P; Michaelis D; Klöting I; Ziegler M
    Acta Diabetol; 1993; 30(4):201-6. PubMed ID: 8180412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Islet cell antibody reactivity with human fetal pancreatic islets.
    Sundkvist G; Bergqvist A; Weibull H; Bergqvist D; Fält K; Olsson ML; Lernmark A
    Diabetes Res Clin Pract; 1991 Oct; 14(1):1-7. PubMed ID: 1748059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of a monoclonal antibody 14A20 that reacts with a 220-kDa protein in the islet cells.
    Sudo Y; Itoh M
    Diabetes Res Clin Pract; 1994 Mar; 23(2):69-76. PubMed ID: 7915225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adult human pancreatic islet cells in tissue culture: function and immunoreactivity.
    Campbell IL; Colman PG; Harrison LC
    J Clin Endocrinol Metab; 1985 Oct; 61(4):681-5. PubMed ID: 2863282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of islet cell surface antigen reactions with islet cell surface antibodies (ICSA)].
    Hakamata M; Itoh M
    Nihon Naibunpi Gakkai Zasshi; 1990 Jul; 66(7):700-14. PubMed ID: 2204556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic.
    Radillo O; Nocera A; Leprini A; Barocci S; Mollnes TE; Pocecco M; Pausa M; Valente U; Betterle C; Tedesco F
    Clin Immunol Immunopathol; 1996 Jun; 79(3):217-23. PubMed ID: 8635278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of islet cell antibodies reactivity to a human islet cell line.
    Muñoz A; Gallart T; Gomis R
    J Endocrinol Invest; 1992 Feb; 15(2):109-12. PubMed ID: 1373745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Islet cell autoantibodies and insulin-dependent (type I) diabetes mellitus.
    Yeo PP
    Ann Acad Med Singap; 1985 Apr; 14(2):343-6. PubMed ID: 3898983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histopathological and immunohistochemical analysis of the endocrine and exocrine pancreas in twelve cattle with insulin-dependent diabetes mellitus (IDDM).
    Taniyama H; Hirayama K; Kagawa Y; Kurosawa T; Tajima M; Yoshino T; Furuoka H
    J Vet Med Sci; 1999 Jul; 61(7):803-10. PubMed ID: 10458104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence of islet cell antibody and defective insulin release in children with schistosomiasis.
    Soliman AT; El-Nawawy AA; El-Azzouni OF; Amer EA; Demian SR; El-Sayed MH
    J Trop Pediatr; 1996 Feb; 42(1):46-9. PubMed ID: 8820621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycolipids as the major autoantigens of cytoplasmatic islet cell antibodies.
    Cabrera-Rode E; Diaz-Horta O; Fernandez LE; Carr A; Marquina G; Valiente O; Gonzalez-Suarez RM; Uriarte A
    Autoimmunity; 1995; 20(3):145-51. PubMed ID: 7578875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reactivity of human preformed natural antibodies with various porcine pancreatic cells.
    Zhang W; Xiong P; Liu S
    J Tongji Med Univ; 2001; 21(1):59-61. PubMed ID: 11523250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.